Clinical Outcome Analysis Based on Place of Birth
hypothermia, thrombocytopenia, pulmonary hemorrhage, coagulopathy, metabolic acidosis
GASTRIC BLEEDING, THROMBOCYTOPENIA, PERSISTENT PULMONARY HYPERTENSION, PULMONARY HEMORRHAGE, COAGULOPATHY, METABOLIC ACIDOSIS
Clinical outcome analysis included all recruited neonates, irrespective of the MR data. Among the 123 inborn neonates in the hypothermia (n = 62) vs control (n = 61) groups, the rates of gastric bleeding (17 neonates [27.4%] vs 7 [11.5%]), pulmonary hemorrhage (13 neonates [21.0%] vs 4 [6.6%]), coagulopathy (24 neonates [38.7%] vs 13 [21.3.%]), severe thrombocytopenia (10 neonates [16.1%] vs 3 [4.9%]), persistent metabolic acidosis (9 neonates [14.5%] vs 4 [6.6%]), and persistent pulmonary hypertension (11 neonates [17.7%] vs 7 [11.5%]) during neonatal hospitalization and mortality at discharge (24 neonates [38.7%] vs 19 [31.1%]) revealed higher occurrence in the hypothermia group, although these differences were not statistically significant. At 22 months, no statistically significant differences were noted in mortality (25 of 59 neonates [42.4%] vs 20 of 61 [32.8%]; 